Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus
disease 2019 (COVID-19). About 45% of COVID-19 patients experience several symptoms a …

Hyperactivation of immune responses resulting in excessive release of pro-inflammatory
mediators in alveoli/lung structures is the principal pathological feature of coronavirus …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a causative virus in the
development of coronavirus disease 2019 (Covid-19) pandemic. Respiratory manifestations …

In this paper, we study a Caputo–Fabrizio fractional order epidemiological model for the
transmission dynamism of the severe acute respiratory syndrome coronavirus 2 pandemic …

Long COVID refers to the lingering symptoms which persist or appear after the acute illness.
The dominant long COVID symptoms in the two years since the pandemic began (2020 …

Alzheimer's disease (AD) is one of the most prominent neurodegenerative diseases, which
impairs cognitive function in afflicted individuals. AD results in gradual decay of neuronal …

In December 2019, a small number of cases of pneumonia of unknown origin were
recognized in the city of Wuhan, China. Soon, the disease, whose etiological factor was …

Vinpocetine (VPN) is an alkaloid derivative of vincamine inhibits phosphodiesterase type 1
that increase cyclic guanosine monophosphate and cyclic adenosine monophosphate. VPN …

The emergence of a novel coronavirus viz., severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) in late 2019 and its subsequent substantial spread produced the …

Background and Objectives The relationship between COVID-19 and epilepsy is uncertain.
We studied the potential association between COVID-19 and seizures or epilepsy in the 6 …